Olympus and Proximie Forge Partnership to Transform Digital Healthcare

By Melike Belenli Gümüş

October 29, 2024

Olympus Proximie partnership

The press release from Olympus Europa highlights a significant partnership between Olympus Corporation and Proximie, a global health technology company. This collaboration is centred around Proximie’s innovative health tech platform, which aims to digitise operating rooms and enhance patient care. The newly formed partnership is designed to improve patient outcomes and clinical practices by fostering collaboration and knowledge sharing among healthcare professionals.

Partnership Overview

Olympus Corporation has entered a global partnership with Proximie to offer a market-leading health tech platform that focuses on digitising operating rooms. This partnership is essential for improving patient care and enhancing clinical practices through better collaboration among medical staff.

Proximie’s Platform

Proximie’s cloud-based solution enables physicians to share real-time live clinical video, audio, and imagery from the operating room (OR) with colleagues and vendor partners globally. This facilitates telecollaboration, secure training sessions, and the capture of video content from any source.

Key Features of Proximie’s Platform

The platform is designed to be device-agnostic, enabling compatibility with various devices and allowing access from any browser or mobile device. It supports up to four high-definition, low-latency video feeds, providing essential views of procedures. To facilitate real-time collaboration, the platform includes features such as annotation, chat, and screen sharing. Moreover, the platform streamlines installation by offering tablet control and the ability to connect multiple video signals, making it easy to set up in any tower or clinical space. For moderation and privacy, the platform incorporates comprehensive controls and privacy features to manage sessions effectively. Furthermore, the system offers content management capabilities, allowing users to transform individual expertise into shareable video content.

Regional Agreement

In the EMEA region, Olympus and Proximie have entered into a Reseller Partner Agreement. This partnership allows Olympus to distribute Proximie’s health tech platform products. Customers across Europe, the Middle East, and Africa will now have access to these innovative solutions.

Objectives and Benefits

The partnership aims to break down learning barriers, providing healthcare professionals with the knowledge needed to enhance patient care. The initiative aims to promote clinical and operational best practices by increasing teaching opportunities. It seeks to reach a broader audience of learners. The collaboration plays a crucial role in the future of digital healthcare. Surgeons can meet the rising demand for diagnostic and interventional care, thereby improving global healthcare equity.

Statements from Executives

Engin Demirel, Global Head of Commercialization for Endoscopy Solutions Ecosystem (ESE) at Olympus Corporation, expressed excitement about the partnership, highlighting its potential to improve patient outcomes. Dr. Nadine Hachach-Haram, the Proximie founder and CEO, emphasised the shared commitment to widening access to surgical and procedural knowledge through the health tech platform, ultimately improving global healthcare equity.

About Olympus and Proximie

Olympus: A global medical technology company committed to making people’s lives healthier, safer, and more fulfilling. Olympus partners with healthcare professionals to deliver best-in-class solutions for early detection, diagnosis, and minimally invasive treatment.

Proximie: A global health technology platform focused on digitising operating and diagnostic rooms. The goal of Proximie’s health tech platform is to make surgery more accessible, efficient, and effective through cutting-edge, cloud-based technology.

Reference url

Recent Posts

clinical trial monitoring
Clinical Trial Monitoring: Insights from Q1 2026 EU/EEA Report

By HEOR Staff Writer

May 22, 2026

Clinical trial monitoring shows that in the first quarter of 2026, an average of 208 new clinical trial applications were submitted monthly through the Clinical Trials Information System, yielding 668 total submissions of which 538 received authorisation. The median time from submission to decisi...
Novartis oncology advancements
Novartis Oncology Advancements: Key Trial Findings and Market Implications
Novartis oncology advancements take center stage as the company prepares to unveil findings from more than 65 abstracts at the upcoming ASCO and EHA meetings. These presentations spotlight progress with Pluvicto, Kisqali, and Scemblix while reinforcing the firm’s commitment to transforming outcom...
EUDAMED Implementation 2026
EUDAMED Implementation 2026: Key Changes and National Adaptations
The EUDAMED Implementation 2026 will require mandatory use of four key modules in the European database on medical devices from 28 May 2026. These cover registration of economic operators, device registration via UDI, notified bodies and certificates, plus market surveillance, following earlier v...